DUBLIN–(BUSINESS WIRE)–The “Cell Therapy Technologies Market Share, Size, Trends, Industry Analysis Report, By Product; By Process; By Cell Type; By End-Use; By Region; Segment Forecast, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.
The global cell therapy technologies market size is expected to reach USD 12.27 billion by 2030, according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
The development of cutting-edge cellular therapy technologies has been made possible by the emergence of new technologies. Companies are using new technologies to boost their product development plans by entering into out-licensing or co-development agreements with other parties in addition to expanding their product line.
Researchers are investing a lot of money in the creation of such efficient and secure treatments as an alternative to traditional treatment modalities, which is another factor contributing to the industry expansion. Oncology has the most active clinical trials out of all therapeutic specialties. For clinical research, T cells, CD34+ and/or CD133+ stem cells, and mesenchymal stem/stromal cells are primarily used.
Additionally, a component that was negatively impacted in 2020, further impacting industry growth, is the requirement for successful commercial translation of cell-based therapy technologies. This factor requires large and stable funding.
Cell therapy Technologies Market Report Highlights
Cell therapy equipment segment is anticipated to grow at an escalating over the forecast period owing to act of replacing, mending, restoring, or regenerating damaged tissues, cells, and organs, cell-based therapies have significant potential.
Cell processing accounted for largest of the global revenue share which is due to increased Viral vectors are now the primary delivery modality among end users, as seen by the exponential rise in the number of viral vector-based R&D initiatives.
Stem cells sector is expected to grow during the forecast period. This growth is attributed to increased research and development initiatives taken.
Research institutes and cell banks sector accounted for the largest revenue share over the forecast period due to the widespread of lymphatic and neuro stimulated disorders and researches in accordance to develop a cure for it.
North America is expected to grow at a significant CAGR over the projected period on account of fast acting insulin demand in the region is being driven by rising diabetes rates and an aging population.
The publisher has segmented the cell therapy technologies market report based on product, process, cell type, end-use, and region:
Long-acting insulin, Product Outlook (Revenue – USD Billion, 2022 – 2030)
Media, Sera, and Reagents
Cell Engineering Products
Cell Culture Vessels
Cell Therapy Equipment
Cell Processing Equipment
Single-use Equipment
Other Equipment
Systems and Software
Other Products
Long-acting insulin, Process Outlook (Revenue – USD Billion, 2022 – 2030)
Cell Processing
Cell Preservation
Distribution and Handling
Process Monitoring and Quality Control
Long-acting insulin, Cell Type Outlook (Revenue – USD Billion, 2022 – 2030)
T-Cells
Stem Cells
Other Cells
Long-acting insulin, End-Use Channel Outlook (Revenue – USD Billion, 2022 – 2030)
Biopharmaceutical and Biotechnology Companies
CROs and CMOs
Research Institutes and Cell Banks
Long-acting insulin, Regional Outlook (Revenue – USD Billion, 2022 – 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Global Cell Therapy Technologies Market Insights
5. Global Cell Therapy Technologies Market, by Product
6. Global Cell Therapy Technologies Market, by Process
7. Global Cell Therapy Technologies Market, by Cell Type
8. Global Cell Therapy Technologies Market, by End-Use
9. Global Cell Therapy Technologies Market, by Geography
10. Competitive Landscape
11. Company Profiles
Companies Mentioned
Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Becton Dickinson and Company
Lonza Group
Sartorius AG
Terumo BCT.
For more information about this report visit https://www.researchandmarkets.com/r/gs0oyj
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
